Factor IX Complex (Human) is a Factor IX complex used to prevent and treat bleeding episodes in hemophilia B or vitamin K antagonist therapy. Factor IX Complex is a sterile, lyophilized concentrate composed of a number of Vitamin K-dependent clotting factors found in functioning human plasma.
- Mechanism
- Curator reviewed
Factor IX Complex is a sterile, lyophilized concentrate composed of a number of Vitamin K-dependent clotting factors found in functioning human plasma. Also known as prothrombin complex concentrate, products containing this complex often include Factor IX (antihemophilic factor B), Factor II (prothrombin), Factor X (Stuart-Prower Factor), and low levels of Factor VII (proconvertin) derived from human plasma. Many commercially available products also contain low levels of other antithrombotic proteins. For example, Kcentra(FDA) also contains the antithrombotic proteins C and S, while Bebulin VH (FDA) contains heparin.
This complex of coagulation factors helps replenish clotting factors that may have been lost through warfarin therapy or through a congenital abnormality such as Hemophilia B.
- Primary indication
- Factor IX Complex is indicated for the prevention and control of hemorrhagic episodes in hemophilia B patients.Curator reviewed · 10 structured indications
- First approval
- Canada, 1986 · United States, 1981
- Also known as
- 4F-PCC · APCC · Coagulation factor IX complex human · Coagulation factor IX, II, VII and X in combination · Factor IX Complex
- Code names
- BE1116
- Brand names
Resolves to
What you can answer from here — as of June 15, 2026
Which drugs share a target with Factor IX Complex (Human), and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account